Vitamin B12: How to Interpret Your Result

What Your Vitamin B12 Number Actually Means

Vitamin B12 (cobalamin) is a water-soluble vitamin your body cannot synthesize on its own. Every number on your lab report represents the concentration of cobalamin circulating in your serum, measured in picograms per milliliter (pg/mL) or picomoles per liter (pmol/L). A result of 200 pg/mL equals roughly 148 pmol/L, so always check which unit your lab uses.

The serum B12 test is inexpensive and widely available, but it has a documented accuracy problem: it measures both active and inactive B12 analogs. Roughly 20 to 30% of patients with normal serum B12 may still have functional deficiency at the cellular level, as demonstrated in population data from the Framingham Offspring Study. That is why borderline results between 200 and 400 pg/mL often need a second test.

The Numbers at a Glance

| Result (pg/mL) | Interpretation | Typical Next Step | |---|---|---| | <200 | Deficient | Treat. Check MMA, homocysteine, CBC | | 200 to 299 | Borderline low | Check MMA + homocysteine; treat if elevated | | 300 to 900 | Normal | Reassess risk factors annually | | >900 (no supplements) | Elevated | Rule out liver disease, solid tumors, myeloproliferative disorder | | >900 (on supplements) | Expected | No action needed if supplementing |

Why "Normal" Varies by Lab

Reference ranges are not universal. The Mayo Clinic lists 200 to 900 pg/mL; Cleveland Clinic uses a similar range. The European Federation of Neurological Societies (EFNS) guideline treats anything below 300 pg/mL as potentially deficient when neurological symptoms are present. Your result must always be read alongside your symptoms, your medications, and your diet, not the reference range alone.

What a Low Vitamin B12 Means

A result below 200 pg/mL confirms deficiency. A result between 200 and 300 pg/mL is functionally low for many patients, especially those with neuropathy, fatigue, or cognitive symptoms. The American Academy of Neurology recognizes B12 deficiency as a reversible cause of peripheral neuropathy and myelopathy, making early detection consequential.

Symptoms Linked to Low B12

Low B12 does not always produce symptoms immediately. When it does, the presentation may include:

• Peripheral neuropathy (tingling, numbness, burning in hands or feet)
• Macrocytic or megaloblastic anemia (large, immature red blood cells)
• Glossitis (smooth, inflamed tongue)
• Cognitive slowing, memory lapses, or mood changes
• Subacute combined degeneration of the spinal cord in severe, prolonged cases

The spinal cord complication deserves specific attention. A 2014 review in the New England Journal of Medicine described how untreated B12 deficiency disrupts myelin synthesis, causing posterior and lateral column damage that may be irreversible if not caught early. Neurological symptoms can precede anemia by months.

Most Common Causes of Low B12

Dietary insufficiency. Cobalamin is found almost exclusively in animal products. Strict vegans and vegetarians carry a substantially higher risk. A 2003 study in the American Journal of Clinical Nutrition (N=689) found that vegans had median B12 levels roughly half those of omnivores.

Pernicious anemia. This autoimmune condition destroys gastric parietal cells, eliminating intrinsic factor. Without intrinsic factor, dietary B12 cannot be absorbed in the terminal ileum. Anti-intrinsic factor antibodies are present in 50 to 70% of confirmed cases. Pernicious anemia requires lifelong replacement therapy.

Metformin use. This is one of the most underrecognized causes of B12 depletion in clinical practice. Metformin interferes with calcium-dependent membrane action in the terminal ileum, blocking intrinsic-factor-mediated B12 absorption. A cross-sectional analysis published in Diabetes Care (N=1,146) found that long-term metformin users had a 19% absolute risk of B12 deficiency compared with 5% in controls. The ADA Standards of Care recommend periodic B12 monitoring for all patients on long-term metformin.

Gastric acid suppression. Protein-bound B12 in food requires stomach acid and pepsin to be cleaved before intrinsic factor can bind it. Proton pump inhibitors (PPIs) and H2 blockers taken for more than two years are associated with measurably lower serum B12. The FDA issued a drug safety communication in 2013 acknowledging this risk.

Malabsorption syndromes. Celiac disease, Crohn's disease involving the terminal ileum, and gastric bypass surgery all reduce B12 absorption surface area or intrinsic factor availability.

Age-related gastric atrophy. Atrophic gastritis becomes increasingly common after age 60 and reduces both acid secretion and intrinsic factor production. The NHANES III survey estimated that 6% of adults over 60 are B12-deficient, with another 14 to 16% in the borderline range.

Confirmatory Tests When B12 Is Borderline

Serum B12 between 200 and 400 pg/mL should prompt two additional labs:

1. Methylmalonic acid (MMA). MMA accumulates when B12-dependent enzymatic reactions stall at the cellular level. An elevated MMA (>0.4 micromol/L) confirms functional deficiency even when serum B12 looks adequate. MMA is more sensitive than serum B12 alone, per a comparative analysis in Annals of Internal Medicine.
2. Total homocysteine. Homocysteine rises when B12 (and folate) are insufficient to drive the methionine cycle. Values above 15 micromol/L suggest functional deficiency and are independently associated with cardiovascular and cognitive risk.

A 1996 paper in the New England Journal of Medicine established that elevated homocysteine is a strong independent risk factor for coronary artery disease, lending additional urgency to treating borderline B12.

What a High Vitamin B12 Means

An elevated B12 result above 900 pg/mL in someone not taking B12 supplements is not simply a sign of good nutrition. It warrants investigation. The body tightly regulates B12 absorption through intrinsic factor, so dietary excess alone rarely drives levels this high.

Causes of Elevated B12

Supplementation. This is the most benign explanation. Patients taking high-dose oral cyanocobalamin (1,000 mcg or more daily) or receiving IM injections will reliably show levels in the thousands. No toxicity has been demonstrated from high serum B12 in this context.

Liver disease. The liver stores 1 to 10 mg of B12. Hepatocyte damage from cirrhosis, acute hepatitis, or non-alcoholic fatty liver disease releases stored B12 into circulation. A 2012 study in the European Journal of Gastroenterology and Hepatology found that unexplained elevated B12 had a positive predictive value of 35 to 40% for significant liver pathology when other causes were excluded.

Myeloproliferative neoplasms. Chronic myeloid leukemia (CML), polycythemia vera, and essential thrombocythemia overproduce haptocorrin (a B12-binding protein), driving serum levels into the thousands. Unexplained B12 above 1,000 pg/mL in a non-supplementing patient should prompt a CBC with differential.

Solid tumors. Breast, colon, stomach, pancreatic, and liver cancers have all been associated with paraneoplastic B12 elevation. A French cohort study (N=136) found that elevated B12 without a clear cause was associated with a cancer diagnosis within one year in approximately 15% of patients.

Renal failure. Reduced clearance of B12-binding proteins can cause accumulation even without increased production.

A Practical Decision Framework for Elevated B12

When a patient presents with B12 above 900 pg/mL and is NOT taking supplements, a stepwise workup applies:

1. Confirm the result is not supplement-related (medication reconciliation).
2. Order CBC with differential, liver function tests (AST, ALT, GGT, bilirubin), and a CMP.
3. If CBC or LFTs are abnormal, refer to hematology or hepatology.
4. If all routine labs are normal but B12 remains >1,000 pg/mL on repeat, consider age-appropriate cancer screening (colonoscopy, breast imaging, CT chest/abdomen/pelvis if clinically indicated).
5. Recheck B12 in 3 months. Persistent elevation without a benign explanation needs subspecialty referral.

How to Raise a Low Vitamin B12

Treatment depends entirely on the cause. Not all low B12 responds to the same regimen.

Oral Supplementation

For patients with dietary deficiency or mild malabsorption, oral cyanocobalamin at 1,000 to 2,000 mcg daily is effective and inexpensive. Despite the fact that intrinsic factor is required for typical B12 absorption (in the terminal ileum), very high oral doses can drive passive diffusion across the gut mucosa at roughly 1% efficiency. This means 1,000 mcg oral delivers approximately 10 mcg via passive absorption, which is sufficient for most people.

A Cochrane review (Vidal-Alaball et al., 2005) found that high-dose oral B12 was as effective as intramuscular injections for correcting deficiency in patients with pernicious anemia, though individual absorption may vary.

Intramuscular Injections

Patients with confirmed pernicious anemia, severe neurological symptoms, or documented malabsorption typically need intramuscular (IM) hydroxocobalamin or cyanocobalamin. A standard loading regimen in the United States is 1,000 mcg IM daily for 7 days, then weekly for 4 weeks, then monthly for life. The UK's NICE guidelines use a similar loading schedule for neurological presentations.

Dietary Sources

Animal products are the primary dietary source. Beef liver (approximately 70 mcg per 3 oz serving) is the densest natural source. Clams, salmon, tuna, eggs, and dairy all contribute meaningfully. Fortified cereals and nutritional yeast are the main plant-based options, but fortification levels vary widely and are generally not adequate to treat an established deficiency.

Addressing the Root Cause

Raising B12 without addressing its underlying cause leads to recurrence. Patients on metformin should have B12 checked annually and may need ongoing supplementation with 500 to 1,000 mcg of oral B12 daily. Patients on long-term PPIs who cannot discontinue them may benefit from periodic IM injections. Those with celiac disease need gluten elimination before absorption normalizes.

How to Interpret B12 Results in Specific Populations

Pregnancy and Fertility

B12 is essential for neural tube closure alongside folate. The American College of Obstetricians and Gynecologists (ACOG) recommends adequate B12 intake during pregnancy, particularly for vegetarian and vegan patients. Deficiency during pregnancy is associated with increased neural tube defect risk and has been linked to recurrent pregnancy loss in some observational studies. Target serum levels during pregnancy are generally held above 300 pg/mL by most obstetric clinicians.

Older Adults

Atrophic gastritis affects an estimated 10 to 30% of adults over age 60, impairing both acid secretion and intrinsic factor production. The USPSTF does not currently issue a formal recommendation for routine B12 screening in asymptomatic older adults, but many geriatricians screen annually given the high prevalence of borderline deficiency and the stakes of missed neurological disease.

Patients with Type 2 Diabetes on Metformin

The ADA Standards of Medical Care in Diabetes, 2024 explicitly state: "Periodic measurement of vitamin B12 levels should be considered in metformin-treated patients, especially those with anemia or peripheral neuropathy." This is not a time-limited recommendation. It applies for the full duration of metformin therapy. Clinicians typically check B12 at baseline and then every 2 to 3 years, or sooner if symptoms appear.

Bariatric Surgery Patients

Roux-en-Y gastric bypass and sleeve gastrectomy dramatically reduce the stomach's capacity to produce intrinsic factor and acid. The American Society for Metabolic and Bariatric Surgery recommends lifelong B12 supplementation starting immediately postoperatively. A prospective cohort study found that up to 64% of bypass patients developed B12 deficiency within 4 years without supplementation.

Monitoring After Treatment

Once treatment starts, recheck serum B12 in 8 to 12 weeks to confirm levels are rising. In patients with neurological symptoms, MMA and homocysteine should normalize within 4 to 8 weeks of adequate replacement. Neurological recovery depends on severity and duration of deficiency. Mild neuropathy may fully resolve; established posterior column damage often improves partially but may not reverse completely.

A CBC should be rechecked at 4 to 6 weeks. Macrocytic anemia typically corrects within 6 to 8 weeks. If anemia is slow to respond, evaluate for concurrent iron deficiency or folate deficiency, both of which can co-exist and blunt the hematological response to B12 repletion.